Weller, M; Stupp, R (2009). Approval of new drugs for glioblastoma. Current Opinion in Neurology, 22(6):617-618.
Statistics
Citations
Dimensions.ai Metrics
5 citations in Web of Science®
6 citations in Scopus®
6 citations in Microsoft Academic
Google Scholar™
6 citations in Scopus®
6 citations in Microsoft Academic
Google Scholar™
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Life Sciences > Neurology
Health Sciences > Neurology (clinical) |
| Language: | English |
| Date: | December 2009 |
| Deposited On: | 01 Mar 2010 08:44 |
| Last Modified: | 29 Jul 2020 22:06 |
| Publisher: | Lippincott Wiliams & Wilkins |
| ISSN: | 1080-8248 |
| Additional Information: | This a non-final version of an article published in final form in Current Opinion in Neurology. 22(6):617-618 |
| OA Status: | Green |
| Publisher DOI: | https://doi.org/10.1097/WCO.0b013e3283327cc1 |
| PubMed ID: | 19770759 |
Weller, M